Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000930661-03-000509
Filing Date
2003-02-11
Accepted
2003-02-11 13:39:54
Documents
2
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A AMENDMENT 1 d10ka.htm 10-K/A 1125904
3 CONSENT OF INDEPENDENT AUDITORS dex231.htm EX-23.1 2113
  Complete submission text file 0000930661-03-000509.txt   1129631
Mailing Address 2950 WILDERNESS PLACE BOULDER CO 80301
Business Address 2950 WILDERNESS PLACE BOULDER CO 80301 3034496500
RIBOZYME PHARMACEUTICALS INC (Filer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27914 | Film No.: 03549572
SIC: 2834 Pharmaceutical Preparations